Alligator Bioscience logo

Alligator Bioscience Investor Relations Material

Alligator Bioscience AB, is a research-based biotechnology company, which specialises in the development of novel antibody-based drugs for cancer treatment with a foundation in Sweden. The Company's pipeline includes anti-carcinoembryonic antigen monoclonal antibody, called GA101, which has demonstrated significant efficacy and tolerability in several clinical trials. The company is based in Lund, Sweden

Upcoming events for

Q2 20222022-07-12

Latest company events

Ticker symbol

ATROX

Country

Sweden

Dig deeper into the Alligator Bioscience fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot